FDA Inspection 989287 — Anna Tinker
The FDA completed an inspection of Anna Tinker on September 22, 2016 in Vancouver. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vancouver (Canada)
Additional Details
Clinical Investigator (CI)